Richard C. Dage - Concepedia

Author

Richard C. Dage

Union Institute & University

Also Known As

R C Dage, R. C. DAGE, R. C. Dage, R.C DAGE, R.C. Dage, RICHARD C. DAGE, Richard C Dage, Richard C. Dage

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Union Institute & University Marion Local Schools Merrell University of Beauty Arts and Science

About

Richard C. Dage is an author at Union Institute & University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	883
2	Anesthesia	10	10	334
3	Biochemistry	5	5	411
4	Natural Sciences	4	4	358
5	Health Sciences	2	2	84

Richard C. Dage

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043 Takashi Kariya, Louis J. Wille, Richard C. Dage Journal of Cardiovascular Pharmacology Chemical BiologyCardiovascular ToxicityCardiomyopathyCardiac MusclePde Iii	1982	152
Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart. David Rampe, Barbara A. Wible, Arthur Brown, Molecular Pharmacology	1993	140
Cardiovascular Properties of a New Cardiotonic Agent Richard C. Dage, Lawrence E. Roebel, Chih Peng Hsieh, Journal of Cardiovascular Pharmacology Heart FailureCardiac AnaesthesiaCardiovascular PropertiesCardiovascular PharmacologyPharmacotherapy	1982	114
An acyl-iminium ion cyclization route to a novel conformationally restricted dipeptide mimic: applications to angiotensin-converting enzyme inhibition Gary A. Flynn, Eugène L. Giroux, Richard C. Dage Journal of the American Chemical Society Bioorganic ChemistryAltmetric Attention ScoreOrganic ChemistryPeptide ScienceChemical Biology	1987	97
Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one) Lawrence E. Roebel, Richard C. Dage, Hsien C. Cheng, Journal of Cardiovascular Pharmacology	1982	71
Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11 Gary A. Flynn, Douglas W. Beight, Shujaath Mehdi, Journal of Medicinal Chemistry Cardiovascular PharmacologyAltmetric Attention ScorePeptide SciencePharmacotherapyChemical Biology	1993	67
Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart. David Rampe, Barbara A. Wible, David Fedida, Molecular Pharmacology	1993	65
Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase in Rats with Hypertension John F. French, Barbara A. Anderson, Thomas R. Downs, Journal of Cardiovascular Pharmacology HypertensionCardiovascular PharmacologySelective InhibitorsCaptopril TreatmentPharmacotherapy	1995	57
Protection Against Postischemic Myocardial Dysfunction in Anesthetized Rabbits with Scavengers of Oxygen-Derived Free Radicals John Koerner, Barbara A. Anderson, Richard C. Dage Journal of Cardiovascular Pharmacology	1991	54
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents Richard A. Schnettler, Richard C. Dage, J. Martin Grisar Journal of Medicinal Chemistry Heart RateHeart FailureHealth SciencesBiochemistryPharmacological Study	1982	53

Page 1